- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05612997
ZOE-AFFIRM: Relative Validation of a Novel Food Frequency Questionnaire
Relative Validation of a Remote Novel Food Frequency Questionnaire Compared to 24hr Recalls in the ZOE AFFIRM Study
Study Overview
Detailed Description
Research Question:
What is the relative validity of a novel FFQ (Food Frequency Questionnaire) compared to a widely accepted 24h dietary recall tool in a remote setting?
Research Aim:
This study aims to relatively validate the ZFFQ (ZOE Food Frequency Questionnaire; ZOE Ltd) by assessing its agreement with a widely accepted 24h diet recall tool, Intake24 (Newcastle University) in a remote population.
Design:
This study will be conducted in a single-arm design with the intake period under assessment comprising one month.
- Participants will complete two periods of 3 consecutive days each (one weekend-day and two weekdays, i.e. Sunday-Tuesday or Thursday-Saturday), in which they will complete 6 total rounds of Intake24 (one completion per previous 24 hours). The two periods must be at least 14 days apart; participants will be given multiple options of dates to choose from in November/December that satisfy these requirements.
- Once the two recall periods are completed, the participant will be asked to fill out the ZFFQ recalling food frequency (without portion sizes) over the preceding month (which encompasses the two recall periods).
Population: In brief, participants are generally healthy UK-based adults who provided consent to participation in this remote study. Please see the eligibility section for full criteria. Participants provided consent before undertaking any study procedures.
Data analysis: Agreement analysis will be used to compare both dietary assessment methods and evaluate the relative validity of the ZOE FFQ.
Data collection:
- Baseline demographic data (age, sex, BMI, ethnicity, smoking, socio-economic status)
- Dietary data (FFQ and 24hr dietary recall)
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Emily R Leeming, PhD
- Phone Number: 07791131380
- Email: emily.leeming@kcl.ac.uk
Study Contact Backup
- Name: Inbar Linenberg, MS
- Email: inbar.linenberg@kcl.ac.uk
Study Locations
-
-
-
London, United Kingdom
- ZOE Ltd.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Can provide written informed consent
- Are willing and able to comply with all study protocols
- Are willing to complete their dietary recall periods on specified dates
- Have BMI 18 and above
- Are any sex
- Are aged 18 years old and above
- Live in England, Scotland, Wales or Northern Ireland
Exclusion Criteria:
- Do not meet the inclusion criteria.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Relative Validation Arm
|
Food Frequency Questionnaire and 24h Recalls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Food Frequency Questionnaire
Time Frame: 30 days
|
30 days
|
|
24h Recalls
Time Frame: 6 days
|
6 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ZOE-AFFIRM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diet Habit
-
University of Rhode IslandCompletedDiet Modification | Diet HabitUnited States
-
University of ReadingCompletedDiet Modification | Diet, Healthy | Diet HabitUnited Kingdom
-
NewGiza UniversityNot yet recruiting
-
The University of Tennessee, KnoxvilleCompleted
-
NYU Langone HealthCompletedDiet HabitUnited States
-
University of ReadingUniversity of PlymouthEnrolling by invitation
-
NYU Langone HealthNational Institute on Aging (NIA)Completed
-
The University of Tennessee, KnoxvilleCompleted
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
Clinical Trials on Dietary Assessment
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
University Ramon LlullRecruiting
-
PepsiCo Global R&DCompleted
-
Ohio State University Comprehensive Cancer CenterCompletedObesity | Overweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast... and other conditionsUnited States
-
Russian Academy of Medical SciencesRussian Science FoundationRecruitingGastroesophageal Reflux | Esophagitis | GERD | Heartburn | Non-erosive Reflux Disease | Gastroesophageal; Reflux With EsophagitisRussian Federation
-
City of Hope Medical CenterPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Digestive System Carcinoma | Malignant Female Reproductive System Neoplasm | Genitourinary System CarcinomaUnited States
-
Harokopio UniversityEmbryogenesis Assisted Conception UnitCompleted
-
Kocaeli UniversityCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnObesity | Stage I Uterine Corpus Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus CancerUnited States
-
Milton S. Hershey Medical CenterCompletedDietary Habits | Spinal Cord InjuriesUnited States